Medifast Inc. (NYSE: MED) reported Q4 EPS of $0.23, $0.09 worse than the analyst estimate of $0.32. Revenue for the quarter came in at $63 million versus the consensus estimate of $64.67 million.

Sees Q1 revenue of $73.5-$74 million, versus the consensus of $80.70 million.

Earnings Guidance